Pulmonx Corp
(LUNG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,810 | 75,725 | 74,812 | 71,162 | 63,570 |
| Marketable Securities | N/A | 8,759 | 14,147 | 30,577 | 44,467 |
| Receivables | 13,797 | 15,903 | 13,975 | 13,120 | 11,670 |
| Inventories | 16,248 | 16,175 | 16,809 | 16,915 | 16,959 |
| TOTAL | $111,235 | $120,020 | $123,939 | $136,248 | $140,929 |
| Non-Current Assets | |||||
| PPE Net | 2,443 | 2,660 | 2,826 | 2,907 | 2,983 |
| Investments And Advances | 2,474 | 1,892 | 1,376 | 1,681 | 2,266 |
| Intangibles | 2,333 | 2,333 | 2,333 | 2,333 | 2,333 |
| Other Non-Current Assets | 19,796 | 20,282 | 20,262 | 19,681 | 18,890 |
| TOTAL | $27,046 | $27,167 | $26,797 | $26,602 | $26,472 |
| Total Assets | $138,281 | $147,187 | $150,736 | $162,850 | $167,401 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 105 | 104 | 7,803 | 3,176 | 99 |
| Accounts payable and accrued liabilities | 6,420 | 6,557 | 4,280 | 3,827 | 4,576 |
| Accrued Expenses | 14,936 | 14,388 | 11,547 | 16,472 | 12,779 |
| TOTAL | $22,878 | $22,447 | $24,945 | $24,437 | $18,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,025 | 37,011 | 29,393 | 34,002 | 37,137 |
| Deferred Revenues | 92 | 78 | 128 | 135 | 109 |
| Other Non-Current Liabilities | 18,298 | 18,598 | 18,652 | 18,515 | 17,910 |
| TOTAL | $55,370 | $55,650 | $48,124 | $52,604 | $55,176 |
| Total Liabilities | $78,248 | $78,097 | $73,069 | $77,041 | $73,476 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,247 | 40,747 | 40,258 | 39,796 | 39,488 |
| Common Shares | 41 | 41 | 40 | 40 | 39 |
| Retained earnings | -511,133 | -497,176 | -482,003 | -467,555 | -454,380 |
| Other shareholders' equity | 2,238 | 2,636 | 2,202 | 2,113 | 2,534 |
| TOTAL | $60,033 | $69,090 | $77,667 | $85,809 | $93,925 |
| Total Liabilities And Equity | $138,281 | $147,187 | $150,736 | $162,850 | $167,401 |